Literature DB >> 33425136

Human defensins and Th-1 cytokines in hepatitis C viral infection.

Dorcas Ohui Owusu1, Michael Owusu2, Bright Afriyie Owusu1.   

Abstract

INTRODUCTION: active or chronic exacerbated forms of hepatitis C virus (HCV) infection subsequently progress to liver disease and human defensins has been determined to have some level of anti-viral properties invitro whilst the expression of T helper-1 cytokines is known to promote complete recovery from acute HCV infection. The study sought to determine relationship between these immune responses.
METHODS: a cross sectional descriptive study design was employed. Hundred and thirty-two individuals were assessed were assessed for to anti-HCV, HCV RNA, serum levels of human alpha defensins 1 (HAD-1) and human beta defensins 1 (HBD-1). T helper 1 cytokines (IL-2, IFN gamma, TNF alpha) secreted in serum were also analyzed using commercial ELISA assay. The study was conducted in Kumasi, Obuasi and Daboya in Ghana.
RESULTS: the serum mean concentrations of HAD-1, HBD-1, IL-2, IFN gamma and TNF alpha showed no significant difference in concentrations among participants with chronic, spontaneously recovered or negative to HCV infection (p>0.05). Persons with hepatitis B co-infection were more likely to develop chronic HCV infection (p=0.039). HAD-1 and HBD-1 showed significant positive association with IL-2 (p=0.000) whilst only HAD-1 positively correlated with IL-2 (p<0.000).
CONCLUSION: the immunological markers determined had no association with the status of HCV infection. HAD-1 increased with increasing levels of IL-2. These findings suggest that during HCV infection, inflammatory response through the production of cytokines by IL-2 cells may affect the release of HAD-1 and HBD-1. Copyright: Dorcas Ohui Owusu et al.

Entities:  

Keywords:  Hepatitis C; chronic; cytokines; human defensins; spontaneous recovery

Mesh:

Substances:

Year:  2020        PMID: 33425136      PMCID: PMC7757282          DOI: 10.11604/pamj.2020.37.103.25211

Source DB:  PubMed          Journal:  Pan Afr Med J


  16 in total

Review 1.  Defensins: natural component of human innate immunity.

Authors:  Justyna Jarczak; Ewa M Kościuczuk; Paweł Lisowski; Nina Strzałkowska; Artur Jóźwik; Jarosław Horbańczuk; Józef Krzyżewski; Lech Zwierzchowski; Emilia Bagnicka
Journal:  Hum Immunol       Date:  2013-06-10       Impact factor: 2.850

2.  Stimulation of specific cytokines in human conjunctival epithelial cells by defensins HNP1, HBD2, and HBD3.

Authors:  Jing Li; Hong Yuan Zhu; Roger W Beuerman
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-20       Impact factor: 4.799

3.  Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.

Authors:  Robert L Kruse; Jennifer R Kramer; Gia L Tyson; Zhigang Duan; Liang Chen; Hashem B El-Serag; Fasiha Kanwal
Journal:  Hepatology       Date:  2014-10-29       Impact factor: 17.425

4.  Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?

Authors:  G J Park; B P Lin; M C Ngu; D B Jones; P H Katelaris
Journal:  J Gastroenterol Hepatol       Date:  2000-04       Impact factor: 4.029

5.  Virucidal activity of human α- and β-defensins against hepatitis C virus genotype 4.

Authors:  Ehab H Mattar; Hussein A Almehdar; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Mol Biosyst       Date:  2016-08-16

6.  Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells.

Authors:  François Niyonsaba; Hiroko Ushio; Mutsuko Hara; Hidenori Yokoi; Mitsutoshi Tominaga; Kenji Takamori; Naoki Kajiwara; Hirohisa Saito; Isao Nagaoka; Hideoki Ogawa; Ko Okumura
Journal:  J Immunol       Date:  2010-02-26       Impact factor: 5.422

7.  IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3.

Authors:  Cristina Albanesi; Heather R Fairchild; Stefania Madonna; Claudia Scarponi; Ornella De Pità; Donald Y M Leung; Michael D Howell
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

8.  Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa.

Authors:  Daniel Candotti; Jillian Temple; Francis Sarkodie; Jean-Pierre Allain
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis.

Authors:  Laurence Amiot; Nicolas Vu; Michel Rauch; Annie L'Helgoualc'h; Frédéric Chalmel; Hugues Gascan; Bruno Turlin; Dominique Guyader; Michel Samson
Journal:  J Hepatol       Date:  2013-09-12       Impact factor: 25.083

Review 10.  Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review.

Authors:  Maurizio Pompili; Marco Biolato; Luca Miele; Antonio Grieco
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.